GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
Data presented at the 14thInternational Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV®(nintedanib),a leading tyrosine […]